SCHEMBL8565434

SCHEMBL8565434

COc1ccc2nc([C@H](CC(C)C)NC(=O)OCc3ccccc3)[nH]c2c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 9/20 0.78
MMP1 P03956 2/20 0.61
MMP3 P08254 2/20 0.61
MMP7 P09237 2/20 0.61
HDAC3 O15379 2/20 0.50
HDAC4 P56524 2/20 0.50
HDAC1 Q13547 2/20 0.50
HDAC7 Q8WUI4 2/20 0.50
HDAC2 Q92769 2/20 0.50
HDAC10 Q969S8 2/20 0.50
HDAC11 Q96DB2 2/20 0.50
HDAC8 Q9BY41 2/20 0.50
HDAC6 Q9UBN7 2/20 0.50
HDAC9 Q9UKV0 2/20 0.50
HDAC5 Q9UQL6 2/20 0.50
CTSL P07711 2/20 0.47
CTSS P25774 2/20 0.47
CTSK P43235 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
TP53 P04637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8565426 0.93 AAK1 (0.70) AAK1MMP1MMP3MMP7HDAC3
SCHEMBL8565431 0.93 AAK1 (0.70) AAK1MMP1MMP3MMP7HDAC3
SCHEMBL19328179 0.86 AAK1 (1.00) AAK1MMP1MMP3MMP7HDAC3
SCHEMBL17516048 0.86 AAK1 (1.00) AAK1MMP1MMP3MMP7HDAC3
SCHEMBL17516059 0.85 AAK1 (0.86) AAK1MMP1MMP3MMP7HDAC3
SCHEMBL17515986 0.84 AAK1 (0.77) AAK1MMP1MMP3MMP7HDAC3
SCHEMBL17515829 0.84 AAK1 (1.00) AAK1MMP1MMP3MMP7HDAC3
SCHEMBL17515819 0.82 AAK1 (0.86) AAK1MMP1MMP3MMP7HDAC3
SCHEMBL17515977 0.81 AAK1 (0.73) AAK1MMP1MMP3MMP7HDAC3
SCHEMBL17515991 0.80 AAK1 (0.73) AAK1MMP1MMP3MMP7HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0821675-A1 NOVEL HYDROXAMIC ACID AND AMINO-CARBOXYLATE COMPOUNDS AS METALLOPROTEASE AND TNF INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-02-04 EP disclosed
US-5703092-A TREATING ARTHRITIS, OTHER INFLAMMATORY DISEASES MEDIATED BY MATRIX METALLOPROTEINASE AND/OR TUMOR NECROSIS FACTOR THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-12-30 US disclosed
WO-1996033176-A1 NOVEL HYDROXAMIC ACID AND AMINO-CARBOXYLATE COMPOUNDS AS METALLOPROTEASE AND TNF INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-10-24 WO disclosed